White matter volume and cognitive dysfunction in early Huntington's disease
- PMID: 15970729
- DOI: 10.1097/01.wnn.0000152205.79033.73
White matter volume and cognitive dysfunction in early Huntington's disease
Abstract
Background: Structural abnormalities of the striatum and cognitive impairments have consistently been shown in patients with Huntington's disease (HD). Fewer studies have examined other cerebral structures in early HD and potential associations with cognition.
Method: Ten patients with early HD and 10 matched control subjects underwent magnetic resonance imaging to provide quantitative measures (volumes) of cortical gray and white matter and the caudate, putamen, and thalamus. Patients completed the Unified Huntington's Disease Rating Scale, including three cognitive tasks.
Results: Although striatal volumes were clearly reduced, white matter was also morphologically abnormal. Cortical gray matter volume was not significantly correlated with cognitive performance. However, the cognitive tasks were most highly correlated with cerebral white matter and, to a lesser degree, striatal volume.
Conclusions: Cerebral white matter volume may be an important variable to examine in future studies of HD.
Similar articles
-
Executive dysfunction in early stages of Huntington's disease is associated with striatal and insular atrophy: a neuropsychological and voxel-based morphometric study.J Neurol Sci. 2005 Dec 15;239(1):11-9. doi: 10.1016/j.jns.2005.07.007. Epub 2005 Sep 26. J Neurol Sci. 2005. PMID: 16185716
-
Cortical dysfunction in patients with Huntington's disease during working memory performance.Hum Brain Mapp. 2009 Jan;30(1):327-39. doi: 10.1002/hbm.20502. Hum Brain Mapp. 2009. PMID: 18172852 Free PMC article.
-
Thalamic atrophy in Huntington's disease co-varies with cognitive performance: a morphometric MRI analysis.Cereb Cortex. 2005 Jun;15(6):846-53. doi: 10.1093/cercor/bhh185. Epub 2004 Sep 30. Cereb Cortex. 2005. PMID: 15459079
-
In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease.Neurology. 2004 Sep 28;63(6):989-95. doi: 10.1212/01.wnl.0000138434.68093.67. Neurology. 2004. PMID: 15452288
-
The Complexity of Clinical Huntington's Disease: Developments in Molecular Genetics, Neuropathology and Neuroimaging Biomarkers.Adv Neurobiol. 2017;15:129-161. doi: 10.1007/978-3-319-57193-5_5. Adv Neurobiol. 2017. PMID: 28674980 Review.
Cited by
-
Diffusion weighted imaging of prefrontal cortex in prodromal Huntington's disease.Hum Brain Mapp. 2014 Apr;35(4):1562-73. doi: 10.1002/hbm.22273. Epub 2013 Apr 9. Hum Brain Mapp. 2014. PMID: 23568433 Free PMC article.
-
Neural bases of dysphoria in early Huntington's disease.Psychiatry Res. 2008 Jan 15;162(1):73-87. doi: 10.1016/j.pscychresns.2007.04.001. Psychiatry Res. 2008. PMID: 18068955 Free PMC article.
-
Non-Verbal and Verbal Fluency in Prodromal Huntington's Disease.Dement Geriatr Cogn Dis Extra. 2015 Dec 18;5(3):517-29. doi: 10.1159/000441942. eCollection 2015 Sep-Dec. Dement Geriatr Cogn Dis Extra. 2015. PMID: 26955384 Free PMC article.
-
Restoration of CB1 receptor function in hippocampal GABAergic neurons rescues memory deficits in Huntington's disease models.Transl Neurodegener. 2025 Aug 25;14(1):44. doi: 10.1186/s40035-025-00500-w. Transl Neurodegener. 2025. PMID: 40855505 Free PMC article.
-
Loss-of-Huntingtin in Medial and Lateral Ganglionic Lineages Differentially Disrupts Regional Interneuron and Projection Neuron Subtypes and Promotes Huntington's Disease-Associated Behavioral, Cellular, and Pathological Hallmarks.J Neurosci. 2019 Mar 6;39(10):1892-1909. doi: 10.1523/JNEUROSCI.2443-18.2018. Epub 2019 Jan 9. J Neurosci. 2019. PMID: 30626701 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical